General Manager Guo Leifeng of Harbin Gloria Pharmaceuticals (002437.SZ) and his concerted action parties successfully bid for 25 million shares of the company.

Harbin Gloria Pharmaceuticals (002437.SZ) announced that on November 20, 2025, from 10:00 to November 21, 2025, at 10:00 (excluding automatic extension due to bidding), a total of 56.7781 million shares held by shareholder Yu Heng International Investments Corporation and 42.9 million shares held by shareholder Oriental Keystone Investment Limited will be publicly auctioned on the Taobao judicial auction network platform. On November 21, 2025, after checking the results of the public auction on the Taobao judicial auction network platform, the company's director, general manager, and financial responsible person, Mr. Guo Leifeng, and his concerted action person, Tibet Yupan Enterprise Management Partnership Enterprise (Limited Partnership) (referred to as "Tibet Yupan"), participated in the above-mentioned judicial auction, and successfully bid and acquired a total of 25 million shares of the company, accounting for 1.12% of the total share capital of the company.